Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Diarrhea × Endocrine × Clear all

Phase

Status

Completed 2 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 18 Carcinoid Tumor 7 Thyroid Carcinoma, Anaplastic 5 Pheochromocytoma 5 Insulinoma 5 Paraganglioma 4 Vipoma 3 Somatostatinoma 3 Serotonin Syndrome 3 Pituitary Neoplasms 3 Lung Neoplasms 3 Glucagonoma 3 Gastro-enteropancreatic neuroendocrine tumor 3 Gastrinoma 3 Carcinoma, Medullary 3 Thyroid Neoplasms 2 Small Cell Lung Carcinoma 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Neoplasms, Unknown Primary 2 Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Neuroendocrine 2 Carcinoma, Merkel Cell 2 Carcinoma, Islet Cell 2 Breast Neoplasms 2 Zollinger-Ellison Syndrome 1

Interventions

telotristat ethyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04713202 2023-02-10

NET-PACS

Big Ten Cancer Research Consortium

Phase 2 Withdrawn

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡